These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 24659367)
61. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
62. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner. Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934 [TBL] [Abstract][Full Text] [Related]
63. MicroRNA-31 Function as a Suppressor Was Regulated by Epigenetic Mechanisms in Gastric Cancer. Wei J; Wang Z; Wang Z; Yang Y; Fu C; Zhu J; Jiang D Biomed Res Int; 2017; 2017():5348490. PubMed ID: 29333444 [TBL] [Abstract][Full Text] [Related]
64. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9. Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625 [TBL] [Abstract][Full Text] [Related]
65. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
66. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer. Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809 [TBL] [Abstract][Full Text] [Related]
67. Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer. Liu X; Chu KM J Cell Mol Med; 2020 Jun; 24(11):6220-6232. PubMed ID: 32383554 [TBL] [Abstract][Full Text] [Related]
68. miR-215 promotes cell migration and invasion of gastric cancer by targeting Retinoblastoma tumor suppressor gene 1. Chen Z; Liu K; Li L; Chen Y; Du S Pathol Res Pract; 2017 Aug; 213(8):889-894. PubMed ID: 28689850 [TBL] [Abstract][Full Text] [Related]
69. Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells. Li Y; Nie Y; Tu S; Wang H; Zhou Y; Du Y; Cao J; Ye M Oncol Rep; 2016 Oct; 36(4):2108-16. PubMed ID: 27498672 [TBL] [Abstract][Full Text] [Related]
70. Hsa-miR-30a-3p attenuates gastric adenocarcinoma proliferation and metastasis via APBB2. Zhou K; Cao D; Wang Y; Wang L; Meng X Aging (Albany NY); 2021 Jun; 13(12):16763-16772. PubMed ID: 34182542 [TBL] [Abstract][Full Text] [Related]
71. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. Hashimoto Y; Akiyama Y; Yuasa Y PLoS One; 2013; 8(5):e62589. PubMed ID: 23667495 [TBL] [Abstract][Full Text] [Related]
72. miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration of gastric adenocarcinoma cells. Kim YJ; Jeong S; Jung WY; Choi JW; Hwang KC; Kim SW; Lee YC Int J Med Sci; 2020; 17(6):693-701. PubMed ID: 32218690 [TBL] [Abstract][Full Text] [Related]
73. miR-218 tissue expression level is associated with aggressive progression of gastric cancer. Wang XX; Ge SJ; Wang XL; Jiang LX; Sheng MF; Ma JJ Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323107 [TBL] [Abstract][Full Text] [Related]
74. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. Ahadi A IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236 [TBL] [Abstract][Full Text] [Related]
75. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer. Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273 [TBL] [Abstract][Full Text] [Related]
76. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients. Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E Gene; 2020 Oct; 758():144963. PubMed ID: 32683077 [TBL] [Abstract][Full Text] [Related]
78. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Jiang H; Yu WW; Wang LL; Peng Y Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263 [TBL] [Abstract][Full Text] [Related]
79. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. Su Z; Zhao J; Rong Z; Geng W; Wang Z Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660 [TBL] [Abstract][Full Text] [Related]
80. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]